Androgenetic alopecia
12
,
13
|
Topical |
2%/5% |
Superior to placebo, higher efficacy at 5% |
Contact dermatitis, irritation |
5% foam better tolerated |
Androgenetic alopecia
14
|
Oral |
Variable |
Effective for non‐responders to topical form |
Systemic side effects |
Often combined with spironolactone |
Alopecia areata
15
,
16
|
Topical |
3%/5% |
Moderate efficacy, better at higher doses |
Mild local effects |
Limited efficacy in widespread cases |
Alopecia areata
17
|
Oral |
5 mg |
Higher rates of regrowth, but significant side effects |
Systemic side effects |
Used in resistant cases |
Scarring alopecia
18
|
Topical |
2%/5% |
Beneficial in off‐label use |
Contact dermatitis, irritation |
Requires combination with other treatments |
Eyebrows and beard
19
|
Topical |
2%/5% |
Effective in enhancing growth |
Mild local effects |
Off‐label use |